A detailed history of Avantax Advisory Services, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Avantax Advisory Services, Inc. holds 46,342 shares of LLY stock, worth $36.9 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
46,342
Previous 48,957 5.34%
Holding current value
$36.9 Million
Previous $44.3 Million 7.37%
% of portfolio
0.27%
Previous 0.32%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$772.14 - $960.02 $2.02 Million - $2.51 Million
-2,615 Reduced 5.34%
46,342 $41.1 Million
Q2 2024

Aug 09, 2024

BUY
$724.87 - $909.04 $8.4 Million - $10.5 Million
11,584 Added 31.0%
48,957 $44.3 Million
Q1 2024

May 08, 2024

SELL
$592.2 - $792.28 $592 - $792
-1 Reduced -0.0%
37,373 $29.1 Million
Q4 2023

Feb 07, 2024

BUY
$525.19 - $619.13 $462,692 - $545,453
881 Added 2.41%
37,374 $21.8 Million
Q3 2023

Nov 07, 2023

BUY
$434.7 - $599.3 $416,442 - $574,129
958 Added 2.7%
36,493 $19.6 Million
Q2 2023

Aug 11, 2023

BUY
$350.74 - $468.98 $301,285 - $402,853
859 Added 2.48%
35,535 $16.7 Million
Q1 2023

Apr 28, 2023

SELL
$310.63 - $364.82 $539,564 - $633,692
-1,737 Reduced 4.77%
34,676 $11.9 Million
Q4 2022

Feb 13, 2023

BUY
$321.55 - $374.67 $2.26 Million - $2.63 Million
7,030 Added 23.93%
36,413 $13.3 Million
Q3 2022

Nov 01, 2022

SELL
$296.48 - $337.87 $3,261 - $3,716
-11 Reduced 0.04%
29,383 $9.5 Million
Q2 2022

Aug 02, 2022

BUY
$278.73 - $327.27 $537,112 - $630,649
1,927 Added 7.02%
29,394 $9.53 Million
Q1 2022

Apr 27, 2022

SELL
$234.69 - $291.66 $141,283 - $175,579
-602 Reduced 2.14%
27,467 $7.86 Million
Q4 2021

Jan 24, 2022

SELL
$224.85 - $279.04 $42,271 - $52,459
-188 Reduced 0.67%
28,069 $7.76 Million
Q3 2021

Oct 21, 2021

SELL
$221.6 - $272.71 $2,880 - $3,545
-13 Reduced 0.05%
28,257 $6.53 Million
Q2 2021

Jul 29, 2021

BUY
$180.55 - $233.54 $155,634 - $201,311
862 Added 3.15%
28,270 $6.49 Million
Q1 2021

May 13, 2021

BUY
$164.32 - $212.72 $250,752 - $324,610
1,526 Added 5.9%
27,408 $5.12 Million
Q4 2020

Jan 22, 2021

SELL
$130.46 - $172.63 $4.74 Million - $6.28 Million
-36,355 Reduced 58.41%
25,882 $4.37 Million
Q3 2020

Oct 14, 2020

BUY
$146.22 - $169.13 $3.88 Million - $4.49 Million
26,531 Added 74.3%
62,237 $9.22 Million
Q2 2020

Aug 06, 2020

BUY
$136.42 - $164.18 $1.7 Million - $2.05 Million
12,474 Added 53.69%
35,706 $5.87 Million
Q1 2020

Apr 30, 2020

BUY
$119.05 - $147.35 $50,477 - $62,476
424 Added 1.86%
23,232 $3.22 Million
Q4 2019

Feb 14, 2020

BUY
$106.92 - $132.43 $308,464 - $382,060
2,885 Added 14.48%
22,808 $3 Million
Q3 2019

Nov 08, 2019

SELL
$106.79 - $116.16 $91,519 - $99,549
-857 Reduced 4.12%
19,923 $2.23 Million
Q2 2019

Aug 06, 2019

BUY
$110.79 - $129.32 $48,969 - $57,159
442 Added 2.17%
20,780 $2.3 Million
Q1 2019

May 13, 2019

BUY
$111.31 - $131.02 $200,246 - $235,704
1,799 Added 9.7%
20,338 $2.64 Million
Q4 2018

Feb 13, 2019

BUY
$105.9 - $118.64 $1.96 Million - $2.2 Million
18,539 New
18,539 $2.14 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Avantax Advisory Services, Inc. Portfolio

Follow Avantax Advisory Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avantax Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avantax Advisory Services, Inc. with notifications on news.